Prevalence of TMPRSS2–ERG and SLC45A3–ERG gene fusions in a large prostatectomy cohort-Reference-Cited by-同舟云学术

Prevalence of TMPRSS2–ERG and SLC45A3–ERG gene fusions in a large prostatectomy cohort

Published:2010-01-29 Issue:4 Volume:23 Page:539-546
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Esgueva Raquel,Perner Sven,J LaFargue Christopher,Scheble Veit,Stephan Carsten,Lein Michael,Fritzsche Florian R,Dietel Manfred,Kristiansen Glen,Rubin Mark A

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol2009193.pdf

Reference35 articles.

1. Tomlins SA, Rhodes DR, Perner S, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005;310:644–648.

2. Kumar-Sinha C, Tomlins SA, Chinnaiyan AM . Recurrent gene fusions in prostate cancer. Nat Rev Cancer 2008;8:497–511.

3. Tomlins SA, Laxman B, Dhanasekaran SM, et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 2007;448:595–599.

4. Tomlins SA, Bjartell A, Chinnaiyan AM, et al. ETS gene fusions in prostate cancer: from discovery to daily clinical practice. Eur Urol 2009;56:275–286.

5. Clark JP, Cooper CS . ETS gene fusions in prostate cancer. Nat Rev Urol 2009;6:429–439.

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunohistochemical ERG positivity is associated with decreased PSMA expression and lower visibility in corresponding [68Ga]Ga-PSMA-11 PET scans of primary prostate cancer;European Journal of Nuclear Medicine and Molecular Imaging;2024-07-31

2. MIR4435-2HG as a possible novel predictive biomarker of chemotherapy response and death in pediatric B-cell ALL;Frontiers in Molecular Biosciences;2024-04-30

3. Prostein expression in human tumors: a tissue microarray study on 19,202 tumors from 152 different Tumor entities;Diagnostic Pathology;2024-01-13

4. Systematic review and integrated analysis of prognostic gene signatures for prostate cancer patients;Discover Oncology;2023-12-19

5. Biomarkers for Prostate Cancer: From Diagnosis to Treatment;Diagnostics;2023-10-31